Seven resistant and 14 new mutations were detected in 82 BCR::ABL1‐positive ALL subjects pre‐therapy, and P‐loop mutations were most prevalent (n = 5) among resistant mutations. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.